Weight loss and QT interval changes

References (11)

1. Fraley MA, Birchem JA, Senkottaiyan N, Alpert MA. Obesity and the electrocardiogram. Obes Rev 2005; 6: 275-81
2. Bilora F, Vettore G, Barbata A, Pastorello M, Petrobelli F, San Lorenzo I. Electrocardiographic findings in obese subjects. Minerva Gastroenterol Dietol 1999; 45: 193-7 3. Seyfeli E, Duru M, Kuvandik G, Kaya H, Yalcin F. Effect of weight loss on QTc dispersion in obese subjects. Anadolu Kardiyol Derg 2006; 6: 126-9
3. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systemic hypertension. Am J Cardiol 1997;79:508-11
4. Perkiomaki JS, Ikaheimo MJ, Pikkujamsa SM, Rantala A, Lilja M, Kesaniemi YA,et al. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension 1996; 28: 16-21
5. Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA, et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996; 28: 791-6
6. Lim PO, Nys M, Naas AA, Struthers AD, Osbakken M, MacDonald TM. Irbesartan reduces QT dispersion in hypertensive individuals. Hypertension 1999; 33: 713-8
7. Karpanou EA, Vyssoulis GP, Psichogios A, Malakou C, Kyrozi EA, Cokkinos DV, et al. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension. Am Heart J 1998; 136: 765-8
8. Gonzalez-Juanatey JR, Garcia-Acuna JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J, et al. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. Am J Cardiol 1998; 81: 170-4
9. Tomiyama H, Doba N, Fu Y, Kushiro T, Hisaki R, Shinozaki Y, et al. Left ventricular geometric patterns and QT dispersion in borderline and mild hypertension: their evolution and regression. Am J Hypertens 1998; 11: 286-92
10. Galinier M, Balanescu S, Fourcade J, Dorobantu M, Albenque JP, Massabuau P, et al. Prognostic value of arrhythmogenic markers in systemic hypertension. Eur Heart J 1997; 18: 1484-91
11. Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, et al. Report on a Policy Conference of the European Society of Cardiology. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Eur Heart J 2000; 21: 1216-31.